MAP2K7 and colorectal carcinoma: Despite genome-wide CRISPR/Cas9 screening in KRAS mutant CRC cells found that the human ortholog gene (ERN1) could not inhibit the proliferation, the KO of ERN1 rendered sensitivity to MEK inhibitor.